Clinical Trial Update: Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of OROS methylphenidate (Concerta) on attention and memory in children with ADHD. The study has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2011-12-19